The American Medical Association has released updated guidance for private practice physicians navigating the provision of care during the COVID-19 pandemic. The resource emphasizes ways physicians and practices should protect their employees, patients, and visitors while also operating within the…
AAOA’s “Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin.
The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases.
Biologic drugs are monoclonal antibodies targeting specific Type ll inflammation molecular pathways for a variety of disease entities in the head and neck.
Read the article here: